AI Toolkit and Novel Stem Cell Lines
For Assessing Cell Health with Actionable Results
in Large-Scale Manufacturing
BIOINFORMATIC/AI SERVICES
LEVERAGE THE PREDICTIVE POWER OF DIGITAL TWINS
NOVEL STEM CELL LINES (iPSCs)
TO SCALE-UP PRODUCTION, INCREASE CELL BIOMASS YIELDS
CELL THERAPY (CAR-T & iPSCs)
CELL THERAPY (CAR-T & iPSCs)
CELL THERAPY (CAR-T & iPSCs)
OPTIMIZE CELL CULTURE
IN LARGE SCALE MANUFACTURING (2D & 3D)
- Cell health assessment: 50x faster, early detection
- Multi-omics and imaging analysis in the cloud
- Custom assay development and QA/QC tools
- Manage and make sense of internal cell data
- Novel human iPSCs, non-GMO (coming soon)
CULTIVATED MEAT
CELL THERAPY (CAR-T & iPSCs)
CELL THERAPY (CAR-T & iPSCs)
TRANSFORM THE ECONOMICS AND
SCALE-UP PRODUCTION
- Cell health assessment: 50x faster, early detection
- 100x cell media cost reduction services
- Customized cell tissue optimization services
- QA/QC tools: customized classification models
- Novel Bovine iPSCs, non-GMO (coming soon)
OUR PARTNERS AND ADVISORS
CHALLENGE
CURRENT CELL PRODUCTION METHODS AT SCALE ARE INEFFICIENT
- Inadequate bioinformatic/AI tools for efficiently assessing cell health in large-scale manufacturing
- Lack of trustworthy AI to monitor, control and predict cell behaviour in-vitro
- Loss of cell functionality and genetic drifts over time
- Batch losses due to cells failing to meet quality standards
- iPSCs can show batch to batch inconsistencies, heterogeneity
OUR SOLUTION
Predictive AI to Control Cell Culture at Scale, Efficiently
Novel mRNA Method to Develop Consistent, Functional Stem Cell Lines
NEWSLETTER
CONTACT US
Alt Atlas Ltd.
London, UK
Copyright © 2023 Alt Atlas, Stem cells and AI Platform Technology - All rights reserved